Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Brief report: Autologous stem cell transplantation restores immune tolerance in experimental arthritis by renewal and modulation of the Teff cell compartment.

Delemarre EM, Roord ST, van den Broek T, Zonneveld-Huijssoon E, de Jager W, Rozemuller H, Martens AC, Broere F, Wulffraat NM, Glant TT, Prakken BJ, van Wijk F.

Arthritis Rheumatol. 2014 Feb;66(2):350-6. doi: 10.1002/art.38261.

2.

Mesenchymal stem cell therapy in proteoglycan induced arthritis.

Swart JF, de Roock S, Hofhuis FM, Rozemuller H, van den Broek T, Moerer P, Broere F, van Wijk F, Kuis W, Prakken BJ, Martens AC, Wulffraat NM.

Ann Rheum Dis. 2015 Apr;74(4):769-77. doi: 10.1136/annrheumdis-2013-204147. Epub 2014 Jan 6.

PMID:
24395558
3.

In vitro induction of alkaline phosphatase levels predicts in vivo bone forming capacity of human bone marrow stromal cells.

Prins HJ, Braat AK, Gawlitta D, Dhert WJ, Egan DA, Tijssen-Slump E, Yuan H, Coffer PJ, Rozemuller H, Martens AC.

Stem Cell Res. 2014 Mar;12(2):428-40. doi: 10.1016/j.scr.2013.12.001. Epub 2013 Dec 12.

4.

Human regulatory T cells do not suppress the antitumor immunity in the bone marrow: a role for bone marrow stromal cells in neutralizing regulatory T cells.

Guichelaar T, Emmelot ME, Rozemuller H, Martini B, Groen RW, Storm G, Lokhorst HM, Martens AC, Mutis T.

Clin Cancer Res. 2013 Mar 15;19(6):1467-75. doi: 10.1158/1078-0432.CCR-12-2177. Epub 2013 Feb 4.

5.

Spatial distribution and survival of human and goat mesenchymal stromal cells on hydroxyapatite and β-tricalcium phosphate.

Prins HJ, Fernandes H, Rozemuller H, van Blitterswijk C, de Boer J, Martens AC.

J Tissue Eng Regen Med. 2016 Mar;10(3):233-44. doi: 10.1002/term.1681. Epub 2012 Dec 18.

PMID:
23255230
6.

Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma.

Groen RW, Noort WA, Raymakers RA, Prins HJ, Aalders L, Hofhuis FM, Moerer P, van Velzen JF, Bloem AC, van Kessel B, Rozemuller H, van Binsbergen E, Buijs A, Yuan H, de Bruijn JD, de Weers M, Parren PW, Schuringa JJ, Lokhorst HM, Mutis T, Martens AC.

Blood. 2012 Jul 19;120(3):e9-e16. doi: 10.1182/blood-2012-03-414920. Epub 2012 May 31.

PMID:
22653974
7.

Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation.

Noort WA, Oerlemans MI, Rozemuller H, Feyen D, Jaksani S, Stecher D, Naaijkens B, Martens AC, Bühring HJ, Doevendans PA, Sluijter JP.

J Cell Mol Med. 2012 Aug;16(8):1827-39. doi: 10.1111/j.1582-4934.2011.01455.x.

8.

N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.

Groen RW, de Rooij MF, Kocemba KA, Reijmers RM, de Haan-Kramer A, Overdijk MB, Aalders L, Rozemuller H, Martens AC, Bergsagel PL, Kersten MJ, Pals ST, Spaargaren M.

Haematologica. 2011 Nov;96(11):1653-61. doi: 10.3324/haematol.2010.038133. Epub 2011 Aug 9.

9.

HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.

van Meerten T, Rozemuller H, Hol S, Moerer P, Zwart M, Hagenbeek A, Mackus WJ, Parren PW, van de Winkel JG, Ebeling SB, Martens AC.

Haematologica. 2010 Dec;95(12):2063-71. doi: 10.3324/haematol.2010.025783. Epub 2010 Sep 17.

10.

Prospective isolation of mesenchymal stem cells from multiple mammalian species using cross-reacting anti-human monoclonal antibodies.

Rozemuller H, Prins HJ, Naaijkens B, Staal J, Bühring HJ, Martens AC.

Stem Cells Dev. 2010 Dec;19(12):1911-21. doi: 10.1089/scd.2009.0510. Epub 2010 Aug 12.

PMID:
20367498
11.

Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma.

Reijmers RM, Groen RW, Rozemuller H, Kuil A, de Haan-Kramer A, Csikós T, Martens AC, Spaargaren M, Pals ST.

Blood. 2010 Jan 21;115(3):601-4. doi: 10.1182/blood-2009-02-204396. Epub 2009 Nov 13.

PMID:
19965677
12.

Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism.

Schop D, van Dijkhuizen-Radersma R, Borgart E, Janssen FW, Rozemuller H, Prins HJ, de Bruijn JD.

J Tissue Eng Regen Med. 2010 Feb;4(2):131-40. doi: 10.1002/term.224.

PMID:
19842106
13.

Correlation of high-resolution X-ray micro-computed tomography with bioluminescence imaging of multiple myeloma growth in a xenograft mouse model.

Postnov AA, Rozemuller H, Verwey V, Lokhorst H, De Clerck N, Martens AC.

Calcif Tissue Int. 2009 Nov;85(5):434-43. doi: 10.1007/s00223-009-9284-0. Epub 2009 Oct 9.

14.

Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum.

Prins HJ, Rozemuller H, Vonk-Griffioen S, Verweij VG, Dhert WJ, Slaper-Cortenbach IC, Martens AC.

Tissue Eng Part A. 2009 Dec;15(12):3741-51. doi: 10.1089/ten.TEA.2008.0666.

PMID:
19519274
15.

A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.

Rozemuller H, van der Spek E, Bogers-Boer LH, Zwart MC, Verweij V, Emmelot M, Groen RW, Spaapen R, Bloem AC, Lokhorst HM, Mutis T, Martens AC.

Haematologica. 2008 Jul;93(7):1049-57. doi: 10.3324/haematol.12349. Epub 2008 May 19.

16.

Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes.

Rozemuller H, Knaän-Shanzer S, Hagenbeek A, van Bloois L, Storm G, Martens AC.

Exp Hematol. 2004 Nov;32(11):1118-25.

PMID:
15539091
17.

Genetic marking with the DeltaLNGFR-gene for tracing goat cells in bone tissue engineering.

Kruyt MC, Stijns MM, Fedorovich NE, De Bruijn JD, Van Blitterswijk CA, Verbout AJ, Rozemuller H, Hagenbeek A, Dhert WJ, Martens AC.

J Orthop Res. 2004 Jul;22(4):697-702.

19.

GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF.

Rozemuller H, Terpstra W, Rombouts EJ, Lawler M, Byrne C, FitzGerald DJ, Kreitman RJ, Wielenga JJ, Löwenberg B, Touw IP, Hagenbeek A, Martens AC.

Leukemia. 1998 Dec;12(12):1962-70.

20.

In vivo targeting of leukemic cells using diphtheria toxin fused to murine GM-CSF.

Rozemuller H, Rombouts EJ, Touw IP, FitzGerald DJ, Kreitman RJ, Hagenbeek A, Martens AC.

Leukemia. 1998 May;12(5):710-7.

21.

Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor eliminates acute myeloid leukemia cells with the potential to initiate leukemia in immunodeficient mice, but spares normal hemopoietic stem cells.

Terpstra W, Rozemuller H, Breems DA, Rombouts EJ, Prins A, FitzGerald DJ, Kreitman RJ, Wielenga JJ, Ploemacher RE, Löwenberg B, Hagenbeek A, Martens AC.

Blood. 1997 Nov 1;90(9):3735-42.

PMID:
9345060
22.

Sensitivity of human acute myeloid leukaemia to diphtheria toxin-GM-CSF fusion protein.

Rozemuller H, Rombouts EJ, Touw IP, FitzGerald DJ, Kreitman RJ, Pastan I, Hagenbeek A, Martens AC.

Br J Haematol. 1997 Sep;98(4):952-9.

PMID:
9326195
23.

Purification of repopulating hemopoietic cells based on binding of biotinylated Kit ligand.

de Jong MO, Rozemuller H, Kieboom D, Visser JW, Wognum AW, Wagemaker G.

Leukemia. 1996 Nov;10(11):1813-22.

PMID:
8892686
24.

Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.

Rozemuller H, Rombouts WJ, Touw IP, FitzGerald DJ, Kreitman RJ, Pastan I, Hagenbeek A, Martens AC.

Leukemia. 1996 Nov;10(11):1796-803.

PMID:
8892684
25.

The C-terminal cytoplasmic region of the granulocyte colony-stimulating factor receptor mediates apoptosis in maturation-incompetent murine myeloid cells.

Dong F, Pouwels K, Hoefsloot LH, Rozemuller H, Löwenberg B, Touw IP.

Exp Hematol. 1996 Feb;24(2):214-20.

PMID:
8641344
26.

IL-6-induced anaemia in rats: possible pathogenetic implications for anemia observed in chronic inflammations.

Jongen-Lavrencic M, Peeters HR, Rozemuller H, Rombouts WJ, Martens AC, Vreugdenhil G, Pillay M, Cox PH, Bijser M, Brutel G, Breedveld FC, Swaak AJ.

Clin Exp Immunol. 1996 Feb;103(2):328-34.

27.

Biotinylation of interleukin-2 (IL-2) for flow cytometric analysis of IL-2 receptor expression. Comparison of different methods.

De Jong MO, Rozemuller H, Bauman JG, Visser JW.

J Immunol Methods. 1995 Jul 17;184(1):101-12.

PMID:
7622862
28.

The expression of cytokine receptors by purified hemopoietic stem cells.

Visser JW, Rozemuller H, de Jong MO, Belyavsky A.

Stem Cells. 1993 Jul;11 Suppl 2:49-55.

PMID:
7691328
29.

A sensitive method to detect cell surface receptors using biotinylated growth factors.

de Jong MO, Rozemuller H, Visser JW, Bauman JG.

Prog Histochem Cytochem. 1992;26(1-4):119-23. No abstract available.

PMID:
1336610

Supplemental Content

Loading ...
Support Center